CORT - Corcept Therapeutics Incorporated

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 2.36B
Enterprise value 1.90B
Trailing P/E 26.55
Forward P/E 30.58
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.67
Price/book (mrq)4.68
Enterprise value/revenue 4.77
Enterprise value/EBITDA 19.59

Trading information

Stock price history

Beta (5Y monthly) 0.50
52-week change 38.59%
S&P500 52-week change 33.90%
52-week high 330.14
52-week low 317.86
50-day moving average 322.93
200-day moving average 323.83

Share statistics

Avg vol (3-month) 3853.91k
Avg vol (10-day) 3551.72k
Shares outstanding 5101.58M
Implied shares outstanding 6N/A
Float 882.99M
% held by insiders 111.59%
% held by institutions 183.62%
Shares short (14 May 2023) 417.13M
Short ratio (14 May 2023) 424.44
Short % of float (14 May 2023) 427.41%
Short % of shares outstanding (14 May 2023) 416.86%
Shares short (prior month 13 Apr 2023) 417.92M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 22.84%
Operating margin (ttm)24.34%

Management effectiveness

Return on assets (ttm)11.59%
Return on equity (ttm)20.16%

Income statement

Revenue (ttm)413.82M
Revenue per share (ttm)3.86
Quarterly revenue growth (yoy)12.80%
Gross profit (ttm)396.47M
EBITDA 101.38M
Net income avi to common (ttm)94.3M
Diluted EPS (ttm)0.80
Quarterly earnings growth (yoy)-30.30%

Balance sheet

Total cash (mrq)465.06M
Total cash per share (mrq)4.58
Total debt (mrq)575k
Total debt/equity (mrq)0.11
Current ratio (mrq)6.77
Book value per share (mrq)4.90

Cash flow statement

Operating cash flow (ttm)111.03M
Levered free cash flow (ttm)105.44M